Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-14 | IDXX | Johnson Michael Perkins | EVP | M - OptEx | $0.00 | +573 | 2,973 | +24% | $0 |
| D | 2026-02-17 | 2026-02-14 | IDXX | Johnson Michael Perkins | EVP | F - Tax | $629.35 | -178 | 2,795 | -6% | -$112.0K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Johnson Michael Perkins | EVP | M - OptEx | $0.00 | -573 | 356 | -62% | $0 |
| DM | 2026-02-17 | 2026-02-12 | IDXX | Johnson Michael Perkins | EVP | A - Grant | $0.00 | +4,139 | 770 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | M | A | 179 | $0.00 | 2,754.69 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-14 | M | A | 176 | $0.00 | 2,575.69 | D | — | — | (F1) Includes a total of 34.345 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on June 30, 2025, September 30, 2025 and December 31, 2025. There are a total of 163.687 shares held in the ESPP which has been increased by 0.001 shares due to a rounding calculation of previously issued fractional shares. |
| 3 | Common | Common Stock | 2026-02-14 | M | A | 218 | $0.00 | 2,972.69 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-14 | F | D | 178 | $629.35 | 2,794.69 | D | — | — | (F2) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. |
| 5 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 218 | $0.00 | 652 | D | — · — to — | 218 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026. |
| 6 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-12 | A | A | 3,207 | $0.00 | 3,207 | D | $617.20 · — to 2036-02-11 | 3,207 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. |
| 7 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-12 | A | A | 162 | $0.00 | 162 | D | $617.20 · — to 2036-02-11 | 162 Common Stock | (F4) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 770 | $0.00 | 770 | D | — · — to — | 770 Common Stock | (F5) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 176 | $0.00 | 176 | D | — · — to — | 176 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024. |
| 10 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 179 | $0.00 | 356 | D | — · — to — | 179 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. |